KG
MRNA icon

Kilter Group’s Moderna MRNA Stock Holding History

Kilter Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Sell
30
-5
-14% -$259 ﹤0.01% 1004
2026
Q1 		$1.78K Buy
35
+5
+17% +$233 ﹤0.01% 993
2025
Q4 		$885 Buy
30
+20
+200% +$543 ﹤0.01% 1094
2025
Q3 		$259 Sell
10
-20
-67% -$558 ﹤0.01% 1145
2025
Q2 		$828 Buy
+30
New +$790 ﹤0.01% 865

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Kilter Group's MRNA Position: Q2 2026 in Review

Kilter Group reduced its Moderna (MRNA) stake by 14% in Q2 2026, selling an estimated $259 and leaving 30 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Kilter Group first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Kilter Group held 30 shares of Moderna worth $2.1K as of Q2 2026.
  • Kilter Group sold 5 Moderna shares in Q2 2026, an estimated $259.
  • Moderna made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1004 holding.
  • Kilter Group first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.